BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Z, Li W, Chen T, Yang J, Luo L, Zhang L, Sun B, Liang R. Retrospective analysis of the clinicopathological characteristics of gastrointestinal neuroendocrine neoplasms. Exp Ther Med. 2015;10:1084-1088. [PMID: 26622444 DOI: 10.3892/etm.2015.2634] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Pham QD, Mori I, Osamura RY. A Case Report: Gastric Mixed Neuroendocrine-Nonneuroendocrine Neoplasm with Aggressive Neuroendocrine Component. Case Rep Pathol. 2017;2017:9871687. [PMID: 28626594 DOI: 10.1155/2017/9871687] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
2 Schmidt D, Wiedenmann B. Extremely Long Survival under Combined Immunotherapy in a Metastatic Functional Neuroendocrine Neoplasia Patient. Neuroendocrinology 2018;106:381-8. [PMID: 29402823 DOI: 10.1159/000486417] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
3 Li YL, Qiu XD, Chen J, Zhang Y, Li J, Xu JM, Wang C, Qi ZR, Luo J, Tan HY. Clinicopathological characteristics and prognosis of 77 cases with type 3 gastric neuroendocrine tumours. World J Gastrointest Oncol 2020; 12(12): 1416-1427 [PMID: 33362912 DOI: 10.4251/wjgo.v12.i12.1416] [Reference Citation Analysis]
4 Wang J, He A, Feng Q, Hou P, Wu J, Huang Z, Xiao Z, Sun C, Liao W, Wu L. Gastrointestinal mixed adenoneuroendocrine carcinoma: a population level analysis of epidemiological trends. J Transl Med. 2020;18:128. [PMID: 32169074 DOI: 10.1186/s12967-020-02293-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Chen G, Xu Q, Qian S, Wang Z, Wang S. Survival Analysis in Gastrointestinal Neuroendocrine Carcinoma With Bone Metastasis at Diagnosis. Front Surg 2022;9:820725. [DOI: 10.3389/fsurg.2022.820725] [Reference Citation Analysis]
6 Watanabe J, Suwa Y, Ota M, Ishibe A, Masui H, Nagahori K, Tsuura Y, Endo I. Clinicopathological and Prognostic Evaluations of Mixed Adenoneuroendocrine Carcinoma of the Colon and Rectum: A Case-Matched Study. Dis Colon Rectum. 2016;59:1160-1167. [PMID: 27824701 DOI: 10.1097/dcr.0000000000000702] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 4.6] [Reference Citation Analysis]
7 Hamano Y, Moriwaki T, To K, Watahiki T, Yamada T, Sakashita S, Hyodo I. A Neuroendocrine Tumor of Unknown Primary Origin that Responded to Treatment Based on Tumor Grade Progression. Intern Med 2019;58:1087-91. [PMID: 30568142 DOI: 10.2169/internalmedicine.1809-18] [Reference Citation Analysis]
8 Li Y, Bi X, Zhao J, Huang Z, Zhou J, Li Z, Zhang Y, Li M, Chen X, Hu X, Chi Y, Zhao D, Zhao H, Cai J. CEA Level, Radical Surgery, CD56 and CgA Expression Are Prognostic Factors for Patients With Locoregional Gastrin-Independent GNET. Medicine (Baltimore) 2016;95:e3567. [PMID: 27149478 DOI: 10.1097/MD.0000000000003567] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
9 Yang JJ, Huang H, Xiao MB, Jiang F, Ni WK, Ji YF, Lu CH, Ni RZ. Sex comb on midleg like-2 is a novel specific marker for the diagnosis of gastroenteropancreatic neuroendocrine tumors. Exp Ther Med 2017;14:1749-55. [PMID: 28810646 DOI: 10.3892/etm.2017.4677] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Semrau S, Agaimy A, Pavel M, Lubgan D, Schmidt D, Cavallaro A, Golcher H, Grützmann R, Fietkau R. Long-term control with chemoradiation of initially metastatic mixed adenoneuroendocrine carcinoma of the rectum: a case report. J Med Case Rep 2019;13:82. [PMID: 30902067 DOI: 10.1186/s13256-019-1995-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
11 Cui Y, Li X, Gao S, Li Z, Li Y, Lu M, Sun Y. Utility of CT in differentiating liver metastases of well-differentiated gastroenteropancreatic neuroendocrine neoplasms from poorly-differentiated neuroendocrine neoplasms. Chin J Cancer Res 2018;30:31-9. [PMID: 29545717 DOI: 10.21147/j.issn.1000-9604.2018.01.04] [Reference Citation Analysis]
12 Yin X, Shen C, Yin Y, Chen H, Chen H, Yin Y, Han L, Chen J, Tang S, Chen Z, Zhang B. Prognoses in patients with primary gastrointestinal neuroendocrine neoplasms based on the proposed new classification scheme. Asia-Pac J Clin Oncol 2018;14:e37-44. [DOI: 10.1111/ajco.12760] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
13 Guo J, Zhang Q, Bi X, Zhou J, Li Z, Huang Z, Zhang Y, Li M, Chen X, Hu X, Yihebali C, Liang J, Liu J, Zhao J, Cai J, Zhao H. Systematic review of resecting primary tumor in MNETs patients with unresectable liver metastases. Oncotarget 2017;8:17396-405. [PMID: 28030811 DOI: 10.18632/oncotarget.14156] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
14 De Luca-Johnson J, Zenali M. A Previously Undescribed Presentation of Mixed Adenoneuroendocrine Carcinoma. Case Rep Pathol 2016;2016:9063634. [PMID: 27965908 DOI: 10.1155/2016/9063634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
15 Gül-Klein S, Sinn M, Jurmeister PS, Biebl M, Weiß S, Rau B, Bläker H, Pratschke J, Aigner F. Two patients with rare mixed adenoneuroendocrine carcinomas of the rectum. SAGE Open Med Case Rep 2018;6:2050313X18758816. [PMID: 29568525 DOI: 10.1177/2050313X18758816] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
16 Ainechi S, Mann SA, Lin J, Patil D, Sheehan CE, Yang Z, Zuo C, Lee H. Paired Box 5 (PAX5) Expression in Poorly Differentiated Neuroendocrine Carcinoma of the Gastrointestinal and Pancreatobiliary Tract: Diagnostic and Potentially Therapeutic Implications. Appl Immunohistochem Mol Morphol 2018;26:545-51. [PMID: 27941564 DOI: 10.1097/PAI.0000000000000473] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
17 Lou L, Lv F, Wu X, Li Y, Zhang X. Clinical implications of mismatch repair deficiency screening in patients with mixed neuroendocrine non-neuroendocrine neoplasms (MiNEN). Eur J Surg Oncol 2021;47:323-30. [PMID: 32907775 DOI: 10.1016/j.ejso.2020.08.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Silva DJ, Dos Santos J, Vaz AP, Mesquita A. Rectal mixed adenoneuroendocrine carcinoma: Case report. Medicine (Baltimore) 2021;100:e27348. [PMID: 34622834 DOI: 10.1097/MD.0000000000027348] [Reference Citation Analysis]